1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Farmacologia, Toxicologia i Química Terapèutica
  4. Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/157699
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPalomer Tarridas, Francesc Xavier-
dc.contributor.authorBarroso Fernández, Emma-
dc.contributor.authorPizarro Delgado, Javier-
dc.contributor.authorPeña, Lucía-
dc.contributor.authorBotteri, Gaia-
dc.contributor.authorZarei, Mohammad-
dc.contributor.authorAguilar, David-
dc.contributor.authorMontori Grau, Marta-
dc.contributor.authorVázquez Carrera, Manuel-
dc.date.accessioned2020-04-27T15:00:52Z-
dc.date.available2020-04-27T15:00:52Z-
dc.date.issued2018-03-20-
dc.identifier.issn1661-6596-
dc.identifier.urihttp://hdl.handle.net/2445/157699-
dc.description.abstractResearch in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole. PPARβ/δ activation might help prevent the development of metabolic disorders, including obesity, dyslipidaemia, type 2 diabetes mellitus and non-alcoholic fatty liver disease. This review highlights research findings on the PPARβ/δ regulation of energy metabolism and the development of diseases related to altered cellular and body metabolism. It also describes the potential of the pharmacological activation of PPARβ/δ as a treatment for human metabolic disorders-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms19030913-
dc.relation.ispartofInternational Journal of Molecular Sciences, 2018, vol. 19, num. 3, p. 913-
dc.relation.urihttps://doi.org/10.3390/ijms19030913-
dc.rightscc-by (c) Palomer Tarridas, Francesc Xavier et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationHomeòstasi-
dc.subject.classificationObesitat-
dc.subject.classificationDiabetis-
dc.subject.classificationMetabolisme cel·lular-
dc.subject.classificationFarmacologia-
dc.subject.otherHomeostasis-
dc.subject.otherObesity-
dc.subject.otherDiabetes-
dc.subject.otherCell metabolism-
dc.subject.otherPharmacology-
dc.titlePPARβ/δ: A Key Therapeutic Target in Metabolic Disorders-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec680789-
dc.date.updated2020-04-27T15:00:52Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29558390-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
680789.pdf1.34 MBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons